CAJ | 학술논문

心力衰竭目前已成为越来越常见的重要的儿科心血管疾病,β-受体阻滞剂作为治疗心力衰竭常用和具有循证医学证据的药物之一,不仅可明显缓解心力衰竭的症状,而且能够显著减少心血管病事件和降低总病死率,疗效好,安全性高.本文就β-受体阻滞剂治疗小儿心力衰竭的机制、临床应用疗效评价、使用过程中应注意的用药原则及相关事项、临床实践中适宜药物的选择及应用等方面作简要介绍.
심력쇠갈목전이성위월래월상견적중요적인과심혈관질병,β-수체조체제작위치료심력쇠갈상용화구유순증의학증거적약물지일,불부가명현완해심력쇠갈적증상,이차능구현저감소심혈관병사건화강저총병사솔,료효호,안전성고.본문취β-수체조체제치료소인심력쇠갈적궤제、림상응용료효평개、사용과정중응주의적용약원칙급상관사항、림상실천중괄의약물적선택급응용등방면작간요개소.
Heart failure is becoming an increasingly common and significant problem in the field of pediatric cardiology,β-blockers as one of the most important cardiovascular drags in the pharmacopoeia,can not only obviously relieve symptoms of severe heart failure,but also reduce cardiovascular events and allcause mortality significantly,the efficacy is effective and high security.This article reviewed β-blockers in the treatment of children heart failure mechanism,the clinical application evaluation,the basic principles and relevant issues in use process,the appropriate choice and usage according to the clinical indications.